Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

BACKGROUND: New screening technologies and vaccination against human papillomavirus (HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent cervical cancer. We evaluated the cost-effectiveness of alternative screening strategies to inform cervical cancer prevention gu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Burger, E A, Ortendahl, J D, Sy, S, Kristiansen, I S, Kim, J J
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2012
Assuntos:
Epidemiology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341862/
https://ncbi.nlm.nih.gov/pubmed/22441643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.94
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares